CVS Health — May 1, 2025 release

See “Non-GAAP Financial Information” earlier in this press release and endnote (2) later in this press release for more information on how we calculate Adjusted EPS. Year Ending December 31, 2025 Low High In millions, except per share amounts Total Company Per Common Share Total Company Per Common Share Net income attributable to CVS Health (GAAP measure) $ 5,372  $ 4.23  $ 5,624  $ 4.43  Non-GAAP adjustments: Amortization of intangible assets 2,000  1.57  2,000  1.57  Net realized capital losses 21  0.02  21  0.02  Acquisition-related integration costs 135  0.11  135  0.11  Loss on Accountable Care assets 247  0.19  247  0.19  Omnicare litigation charge 387  0.30  387  0.30  Office real estate optimization charges 15  0.01  15  0.01  Tax impact of non-GAAP adjustments (557) (0.43) (557) (0.43) Adjusted income attributable to CVS Health (2) $ 7,620  $ 6.00  $ 7,872  $ 6.20  Weighted average diluted shares outstanding 1,270  1,270  21 Endnotes (1) The Company defines adjusted operating income as operating income (GAAP measure) excluding the impact of amortization of intangible assets, net realized capital gains or losses and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance, such as acquisition-related integration costs, losses on Accountable Care assets, the Omnicare litigation charge, office real estate optimization charges and opioid litigation charges. The CODM uses adjusted operating income as its principal measure of segment performance